BIOQUAL, Inc.
BIOQ
$43.19
-$0.25-0.58%
OTC PK
| 02/28/2025 | 11/30/2024 | 08/31/2024 | 02/29/2024 | 11/30/2023 | |
|---|---|---|---|---|---|
| Net Income | 240.36% | -350.09% | -175.08% | 124.13% | -62.54% |
| Total Depreciation and Amortization | -7.14% | -43.65% | 2.67% | 3.58% | -145.01% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -30.07% | 93.16% | -- | -77.87% | 107.59% |
| Change in Net Operating Assets | -273,600.00% | -279.30% | 29.06% | 100.05% | 279.99% |
| Cash from Operations | -85.29% | -148.48% | -78.18% | -23.57% | 193.81% |
| Capital Expenditure | 91.93% | 92.39% | -156.99% | -5,368.75% | 79.20% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 91.93% | 92.39% | -156.99% | -5,368.75% | 79.20% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | 0.00% | -- | -- | 50.00% |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | 0.00% | -- | -- | 50.00% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -84.63% | -168.97% | -85.00% | -30.61% | 1,500.79% |